title: What is the optimal medical therapy for Marfan syndrome?
authors.affiliation: Smilow Center for Translational Research, Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: reed.pyeritz@uphs.upenn.edu.
authors.forename: Reed E
authors.initials: RE
authors.lastname: Pyeritz
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001011:Aorta / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D008382:Marfan Syndrome / Q000188:drug therapy*
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors